S. Maclennan

发表

Adenosine Modulates HIF-1&agr;, VEGF, IL-8, and Foam Cell Formation in a Human Model of Hypoxic Foam Cells

K. Varani, S. Merighi, S. Gessi, 2010, Arteriosclerosis, thrombosis, and vascular biology.

Pharmacological Comparison of a Recombinant CB1 Cannabinoid Receptor with Its Ga16 Fusion Product

D. Bonhaus, Thomas K. H. Chang, S. Maclennan, 2002, Journal of biomolecular screening.

Evidence for inverse agonism of SR141716A at human recombinant cannabinoid CB1 and CB2 receptors

D. Bonhaus, S. Maclennan, P. Reynen, 1998, British journal of pharmacology.

Receptor specificity and trigemino‐vascular inhibitory actions of a novel 5‐HT1B/1D receptor partial agonist, 311C90 (zolmitriptan)

G. Martin, J. Buckingham, A. Robertson, 1997, British journal of pharmacology.

5‐HT1‐like receptors requiring functional cyclo‐oxygenase and 5‐HT2 receptors independent of cyclo‐oxygenase mediate contraction of the human umbilical artery

J. McGrath, M. Whittle, S. Maclennan, 1989, British journal of pharmacology.

A3 adenosine receptors modulate hypoxia-inducible factor-1alpha expression in human A375 melanoma cells.

K. Varani, P. Mirandola, S. Merighi, 2005, Neoplasia.

A3 Adenosine Receptor Activation Inhibits Cell Proliferation via Phosphatidylinositol 3-Kinase/Akt-dependent Inhibition of the Extracellular Signal-regulated Kinase 1/2 Phosphorylation in A375 Human Melanoma Cells*

K. Varani, P. Mirandola, S. Merighi, 2005, Journal of Biological Chemistry.

Oxidative/nitrosative stress selectively altered A2B adenosine receptors in chronic obstructive pulmonary disease

M. Triggiani, I. Adcock, K. Chung, 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Modulation of the Akt/Ras/Raf/MEK/ERK pathway by A3 adenosine receptor

K. Varani, P. Mirandola, S. Merighi, 2006, Purinergic Signalling.

Actions of non-peptide ergot alkaloids at 5-HT1-like and 5-HT2 receptors mediating vascular smooth muscle contraction

G. Martin, S. Maclennan, G. Martin, 1990, Naunyn-Schmiedeberg's Archives of Pharmacology.

[3H]OSIP339391, a selective, novel, and high affinity antagonist radioligand for adenosine A2B receptors.

A. Castelhano, S. Maclennan, B. Mckibben, 2004, Biochemical pharmacology.

Cardiovascular effects of rilmenidine, moxonidine and clonidine in conscious wild‐type and D79N α2A‐adrenoceptor transgenic mice

R. Eglen, J. Jasper, J. Lesnick, 1999, British journal of pharmacology.

Characterization of (cid:97) 2 -adrenoceptors mediating contraction of dog saphenous vein: identity with the human (cid:97) 2A subtype

R. Eglen, J. Jasper, Z. To, 1997 .

Effects of cannabinoid receptor agonists on neuronally‐evoked contractions of urinary bladder tissues isolated from rat, mouse, pig, dog, monkey and human

G. Martin, R. Eglen, R. S. Martín, 2000, British Journal of Pharmacology.

The effect of forskolin on 5‐HT1‐like and angiotensin II‐induced vasoconstriction and cyclic AMP content of the rabbit isolated femoral artery

G. Martin, V. Wilson, S. Maclennan, 1996, British journal of pharmacology.

Characterization of the receptor mediating contraction of human umbilical artery by 5-hydroxytryptamine.

J. McGrath, S. Maclennan, K. Stuart-Smith, 1985, British journal of pharmacology.

Characterization of human recombinant α2A‐adrenoceptors expressed in Chinese hamster lung cells using intracellular Ca2+ changes: evidence for cross‐talk between recombinant α2A‐ and native α1‐adrenoceptors

G. Martin, R. Eglen, S. Maclennan, 2000 .

Characterization of human recombinant α2A‐adrenoceptors expressed in Chinese hamster lung cells using extracellular acidification rate changes

G. Martin, R. Eglen, R. S. Martín, 2000, British journal of pharmacology.

Characterization of human recombinant a2A-adrenoceptors expressed in Chinese hamster lung cells using intracellular Ca changes: evidence for cross-talk between recombinant

G. Martin, R. Eglen, S. Maclennan, 2022 .

Skin permeability and pharmacokinetics of diclofenac epolamine administered by dermal patch in Yorkshire-Landrace pigs

C. Paterson, Susanna Tse, S. Maclennan, 2012, Journal of Pain Research.

Amplifying interactions between spasmogens in vascular smooth muscle.

G. Martin, S. Maclennan, M. Bolofo, 1993, Biochemical Society transactions.

Analysis of the 5-HT receptor in rabbit saphenous vein examplifies the problems of using exclusion criteria for receptor classification

G. Martin, S. Maclennan, 1990, Naunyn-Schmiedeberg's Archives of Pharmacology.

Temperature Dependence of Agonist and Antagonist Affinity Constants at 5-HT 1 -like and 5-HT 2 Receptors

G. Martin, S. Maclennan, D. Prentice, 1991 .

Contraction of human umbilical artery, but not vein, by oxygen.

J. McGrath, M. Whittle, S. Maclennan, 1986, The Journal of physiology.

Alteration of adenosine receptors in patients with chronic obstructive pulmonary disease.

I. Adcock, K. Chung, P. Barnes, 2006, American journal of respiratory and critical care medicine.

Hypoxia Inhibits Paclitaxel-Induced Apoptosis through Adenosine-Mediated Phosphorylation of Bad in Glioblastoma Cells

K. Varani, P. Mirandola, S. Merighi, 2007, Molecular Pharmacology.

Effect of the thromboxane A2‐mimetic U46619 on 5‐HT1‐like and 5‐HT2 receptor‐mediated contraction of the rabbit isolated femoral artery

G. Martin, S. Maclennan, 1992, British journal of pharmacology.

Inhibition of the oxygen-induced contraction of the isolated human umbilical artery by indomethacin, flurbiprofen, aspirin and drugs modifying Ca2+ disposition.

J. McGrath, M. Whittle, S. Maclennan, 1988, Prostaglandins.

Characterization of α2‐adrenoceptors mediating contraction of dog saphenous vein: identity with the human α2A subtype

R. Eglen, J. Jasper, Z. To, 1997 .

Cranial vascular effects of zolmitriptan, a centrally active 5-HT1B/1D receptor partial agonist for the acute treatment of migraine.

G. Martin, S. Maclennan, D. Cambridge, 1998, European journal of pharmacology.

A2A adenosine receptor overexpression and functionality, as well as TNF‐α levels, correlate with motor symptoms in Parkinson's disease

P. Fazio, E. Granieri, K. Varani, 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

A3 Adenosine Receptors, HIF-1 Modulation and Atherosclerosis

S. Gessi, P. Borea, E. Leung, 2010 .

Adenosine modulates vascular endothelial growth factor expression via hypoxia-inducible factor-1 in human glioblastoma cells.

K. Varani, P. Mirandola, S. Merighi, 2006, Biochemical pharmacology.

Modulation of metalloproteinase-9 in U87MG glioblastoma cells by A3 adenosine receptors.

K. Varani, S. Merighi, S. Gessi, 2010, Biochemical pharmacology.

Caffeine Inhibits Adenosine-Induced Accumulation of Hypoxia-Inducible Factor-1α, Vascular Endothelial Growth Factor, and Interleukin-8 Expression in Hypoxic Human Colon Cancer Cells

K. Varani, P. Mirandola, C. Simioni, 2007, Molecular Pharmacology.

Tryptamine fingerprints in the classification of 5-hydroxytryptamine receptors

G. Martin, P. Leff, S. Maclennan, 1990 .

Is NS1619 A BK-Ca channel opener in human bronchus?

M. A. Pate, E. Chilvers, S. Maclennan, 1995 .

Invited Lectures

K. Varani, E. Ragazzi, P. Mirandola, 2006, Purinergic Signalling.

Characterization of alpha 2-adrenoceptors mediating contraction of dog saphenous vein: identity with the human alpha 2A subtype.

R. Eglen, J. Jasper, Z. To, 1997, British journal of pharmacology.

A novel series of 2,5-substituted tryptamine derivatives as vascular 5HT1B/1D receptor antagonists.

G. Martin, A. Robertson, S. Maclennan, 1997, Journal of medicinal chemistry.

Modulation of metalloproteinase-9 in U87MG glioblastoma cells by A3 adenosine receptors.

K. Varani, S. Merighi, S. Gessi, 2010, Biochemical pharmacology.

Comparison of the effects of oxygen, 5-hydroxytryptamine, bradykinin and adrenaline in isolated human umbilical artery smooth muscle.

J. McGrath, M. Whittle, S. Maclennan, 1988, Quarterly journal of experimental physiology.